Biggest News Aggregation in the World
📰 Pfizer Data News

Pfizer Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pfizer Data. Real-time updates on events, politics, business and more.

Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer

Pfizer Inc. today announced overall survival results from the Phase 3 PALOMA-2 trial, which evaluated IBRANCE® in combination with letrozole compared to placebo plus letrozole for the... | June 4, 2022
United States New York Richard Finn Chris Boshoff World Evidence Program American Society Of Clinical Oncology

CNN The Lead With Jake Tapper September 20, 2021 20:03:00

Vaccinated. cnns jason carroll reports, were still waiting for important details about when shots will go into these arms. >> reporter: its information parents of younger children have been waiting for. pfizer sharing data that shows its vaccine is safe for 5 to 11-year-olds and elicits a robust antibody response. >> this is going to make a huge difference in the fight against covid-19 and parents, pediatricians and teachers are waiting for this. >> reporter: pfizer plans to submit its data to t...
London Breed Jason Carroll Reports Covid 19 Antibody Response Emergency Use Authorization Pfizer Data

XELJANZ® Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis

Pfizer Inc. announced today that the European Commission has approved XELJANZ ® for the treatment of active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in patients two years of age and older who have responded inadequately to previous therapy with disease modifying antirheumatic drugs . Two formulations were approved, a tablet and a new oral solution . XELJANZ is the first and only ...
Christopher Stevo Dervila Keane Steve Danehy Paula Carvalho Pharmacovigilance Risk Assessment Committee European Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Data Published in New England Journal of Medicine Shows Pfizer's Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia

Trial demonstrates cumulative incidence of death or respiratory failure through day 28 was 18.1% with tofacitinib compared to 29.0% with placebo, in hospitalized patients with COVID-19 pneumonia Multi-center, randomized, double-blind, placebo-controlled trial conducted across 15 sites in Brazil Tofacitinib is not approved or authorized for the treatment of COVID-19 patients. Tofacitinib should not be used in … Trial demonstrates cumulative incidence of death or respiratory failure through da...
Sao Paulo Tamas Koncz Otavio Berwanger Israelita Albert Einstein Steve Danehy Chuck Triano

Coronavirus Disease Weekly News 13June 2021

Written by rjs, MarketWatch 666The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.
South Africa United States Pan American Health Organization District Of Columbia Hong Kong West Virginia

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science